NCT03206177 | Carcinosarcoma, Ovarian | Phase 1 | Recruiting | June 1, 2022 | United States, Oklahoma
... more >>
University of Oklahoma Health Sciences Center
Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Kathleen Moore, MD Collapse << |
NCT01373164 | Neoplasms
Neo... more >>plasm Metastasis
Pancreatic Cancer Collapse << | Phase 1
Phase 2 | Completed | - | United States, Florida
... more >>
Florida Hospital Tampa HPG and Foregut Surgery
Tampa, Florida, United States, 33613
United States, Illinois
Ingalls Memorial Hospital
Harvey, Illinois, United States, 60426
United States, Washington
Seattle Cancer Care Alliance
Seattle, Washington, United States, 98109
Belgium
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Brussel, Belgium, 1000
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Liège, Belgium, 4000
France
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Besancon, France, 25030
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Clermont-Ferrand, France, 63003
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Marseille, France, 13273
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Montbéliard, France, 25250
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Paris, France, 75674
Germany
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Frankfurt, Germany, 60596
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Friedrichshafen, Germany, 88045
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Leipzig, Germany, 04103
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Marburg, Germany, 35043
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Munich, Germany, 81925
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Mönchengladbach, Germany, 41063
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Reutlingen, Germany, 72764
Italy
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Bergamo, Italy, 24128
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Bologna, Italy, 40138
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Verona, Italy, 37134
Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Barcelona, Spain, 08035
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Madrid, Spain, 28033
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Pozuelo De Alarcon, Spain, 28223
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Sevilla, Spain, 41013 Collapse << |
NCT01373164 | - | - | Completed | - | - |
NCT01682187 | Glioma | Phase 1 | Active, not recruiting | May 1, 2019 | United States, Maryland
... more >>
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Baltimore, Maryland, United States
Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Barcelona, Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Madrid, Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Sevilla, Spain Collapse << |
NCT01220271 | Glioma | Phase 1
Phase 2 | Completed | - | United States, California
... more >>
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
La Jolla, California, United States, 92093
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
San Francisco, California, United States, 94143
United States, Florida
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tampa, Florida, United States, 33612
United States, Illinois
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chicago, Illinois, United States, 60611
United States, Indiana
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Indianapolis, Indiana, United States, 46202
United States, North Carolina
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Durham, North Carolina, United States, 27710
Germany
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Frankfurt, Germany, 60596
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Heidelberg, Germany, 69120
Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Barcelona, Spain, 08035
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Madrid, Spain, 28041 Collapse << |
NCT01246986 | Carcinoma, Hepatocellular | Phase 2 | Active, not recruiting | December 3, 2018 | - |
NCT01582269 | Glioblastoma | Phase 2 | Active, not recruiting | December 31, 2019 | - |
NCT02538471 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | August 2019 | United States, New York
... more >>
Weill Cornell Medical College
New York, New York, United States, 10065 Collapse << |
NCT02178358 | Hepatocellular Carcinoma | Phase 2 | Active, not recruiting | December 31, 2018 | China
... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Beijing, China, 100036
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Bengbu, China, 233004
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Changchun, China, 130012
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Hangzhou, China, 310016
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Hefei, China, 230022
Hong Kong
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Hong Kong, Hong Kong
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Kowloon, Hong Kong
Korea, Republic of
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Incheon, Korea, Republic of, 405-760
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Seoul, Korea, Republic of, 135 720
Taiwan
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Gwei Shan Township, Taiwan, 333
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Liouying/Tainan, Taiwan, 736
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Puzih City, Taiwan, 613
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tainan, Taiwan, 70403
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Taipei, Taiwan, 11217
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Taoyuan, Taiwan, 33378
Thailand
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Bangkok, Thailand, 10330 Collapse << |
NCT02672475 | Estrogen Receptor Negative
... more >> HER2/Neu Negative
Progesterone Receptor Negative
Recurrent Breast Carcinoma
Stage IV Breast Cancer
Triple-Negative Breast Carcinoma Collapse << | Phase 1 | Recruiting | June 2021 | United States, Tennessee
... more >>
Vanderbilt University/Ingram Cancer Center
Recruiting
Nashville, Tennessee, United States, 37232
Contact: G. VICC Clinical Trials Information Program 800-811-8480
Principal Investigator: Vandana G. Abramson, MD Collapse << |
NCT02008318 | Myelodysplastic Syndromes | Phase 2
Phase 3 | Completed | - | Germany
... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Dresden, Germany, 01307
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Düsseldorf, Germany, 40479
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Jena, Germany, 07747
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Lübeck, Germany, 23562
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Ulm, Germany, 89081
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Westerstede, Germany, 26655
Italy
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Firenze, Italy, 50134
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Novara, Italy, 28100
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Rome, Italy, 00161
Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Barcelona, Spain, 08035
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Madrid, Spain, 28050
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Oviedo, Spain, 33011
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Salamanca, Spain, 37007
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Valencia, Spain, 46026 Collapse << |
NCT03470350 | Colorectal Cancer Metastatic | Phase 1
Phase 2 | Recruiting | June 1, 2020 | Netherlands
... more >> Antoni van Leeuwenhoek (NKI-AVL)
Recruiting
Amsterdam, Noord-Holland, Netherlands, 1066 CX
Contact: S Huijberts, MD +31 (0)20-5129111 s.huijberts@nki.nl
Contact: N Steeghs, MD +31 (0)20-5129111 n.steeghs@nki.nl
Principal Investigator: N Steeghs, Dr.
Sub-Investigator: S Huijberts, MD Collapse << |
NCT02734160 | Metastatic Pancreatic Cancer | Phase 1 | Active, not recruiting | June 17, 2019 | United States, Arizona
... more >>
Honor Health Research Institute
Scottsdale, Arizona, United States, 85258
United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
United States, Tennessee
Sarah Cannon Research Institute SCRI
Nashville, Tennessee, United States, 37203
Tennessee Oncology PLLC
Nashville, Tennessee, United States, 37203
France
Gustave Roussy
Villejuif Cedex, France, 94805
Italy
Ospedale Policlinico Giambattista Rossi, Borgo Roma
Verona, Italy, 37134
Korea, Republic of
Samsung Medical Center
Seoul, Korea, Korea, Republic of, 06351
Seoul National University Hospital
Seoul, Korea, Republic of, 03080
Spain
Hospital Universitari Vall d'Hebron
Barcelona, Spain, 08035
Hospital Universitario 12 de Octubre
Madrid, Spain, 28041
Hospital Madrid Norte Sanchinarro
Madrid, Spain, 28050 Collapse << |
NCT02304419 | Neoplasm | Phase 1 | Completed | - | United States, New York
... more >>
Memorial Sloan Kettering Cancer Center
New York City, New York, United States, 10065 Collapse << |
NCT02452008 | Prostate Cancer | Phase 2 | Recruiting | July 2021 | United States, District of Col... more >>umbia
Sibley Memorial Hospital
Recruiting
Washington, District of Columbia, United States, 20016
Contact: Janice Powers, RN 202-660-5772 jpower22@JHMI.EDU
Principal Investigator: Channing Paller, MD
United States, Illinois
Northwestern University
Recruiting
Chicago, Illinois, United States, 60611
Contact: Maha Hussain, MD 312-908-5487 maha.hussain@northwestern.edu
Principal Investigator: Maha Hussain, MD
University of Chicago
Recruiting
Chicago, Illinois, United States, 60637
Contact: Russel Szmulewitz, MD 773-702-7609 rszmulew@medicine.bsd.uchicago.edu
Contact: Kelly O'Connor 773-702-4653 koconnor@medicine.bsd.uchicago.edu
Principal Investigator: Russel Szmulewitz, MD
United States, Maryland
Johns Hopkins University
Recruiting
Baltimore, Maryland, United States, 21205
Contact: Channing Paller, MD 410-614-6321 cpaller@JHMI.EDU
Contact: Irina Rifkind, RN 410-502-2043 irifkin1@JHMI.EDU
Principal Investigator: Channing Paller, MD Collapse << |
NCT02688712 | Rectal Adenocarcinoma | Phase 2 | Recruiting | June 2022 | United States, Oregon
... more >>
Providence Cancer Center
Recruiting
Portland, Oregon, United States, 97213
Contact: Larissa Lundgren 503-215-2614 Larisa.Lundgren@providence.org
Sub-Investigator: Walter J. Urba, M.D., Ph.D
Sub-Investigator: Rachel Sanborn, MD
Sub-Investigator: Todd Crocenzi, MD
Sub-Investigator: Bernard Fox, Ph.D
Sub-Investigator: Michael Gough, Ph.D.
Sub-Investigator: Stephen Bader, MD
Sub-Investigator: Alice Wang-Chesebro, MD
Sub-Investigator: Matthew Solhjem, MD
Sub-Investigator: Rui Li, MD, PhD
Sub-Investigator: Rom Leidner, MD
Sub-Investigator: Marka Crittenden, MD, PhD
Sub-Investigator: Steven Seung, MD, PhD
Sub-Investigator: Mark Whiteford, MD
Sub-Investigator: David Page, MD
Sub-Investigator: John Godwin, MD Collapse << |
NCT01746004 | Healthy Volunteers | Phase 1 | Completed | - | United States, Wisconsin
... more >>
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Madison, Wisconsin, United States, 53704 Collapse << |
NCT02752919 | Healthy | Phase 1 | Completed | - | United Kingdom
... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Leeds, West Yorkshire, United Kingdom Collapse << |
NCT01965808 | Healthy Volunteers | Phase 1 | Completed | - | United States, Florida
... more >>
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Daytona Beach, Florida, United States, 31227 Collapse << |
NCT01722825 | Neoplasms
Neo... more >>plasm Metastasis Collapse << | Phase 1 | Completed | - | Japan
... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559 ) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tokyo, Japan, 104-0045 Collapse << |
NCT02154646 | Pancreatic Neoplasms | Phase 1 | Completed | - | Japan
... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chiba, Japan, 277 8577
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tokyo, Japan, 104-0045 Collapse << |
NCT02240433 | Hepatocellular Carcinoma | Phase 1 | Active, not recruiting | February 11, 2019 | Japan
... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chiba, Japan, 277 8577
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Kanagawa, Japan, 241-8515
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Suita-shi, Japan, 565-0871 Collapse << |
NCT02423343 | Solid Tumor
N... more >>on-Small Cell Lung Cancer Recurrent
Hepatocellular Carcinoma Recurrent Collapse << | Phase 1
Phase 2 | Recruiting | December 20, 2019 | United States, Alabama
... more >>
University of Alabama at Birmingham Medical Center
Recruiting
Birmingham, Alabama, United States, 35294
Contact 2059961403
Principal Investigator: Mansoor Noorali Saleh
United States, California
University of California - San Diego
Recruiting
La Jolla, California, United States, 92093
Contact 858-534-3804
Principal Investigator: Sandip Patel
United States, Florida
H Lee Moffitt Cancer Center
Recruiting
Tampa, Florida, United States, 33612-9497
Contact 813-745-2677
Principal Investigator: Scott J Antonia
United States, Massachusetts
Dana Farber Cancer Institute
Recruiting
Boston, Massachusetts, United States, 02215
Contact 617-632-2166
Principal Investigator: David A Reardon
United States, Texas
University of Texas MD Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contact 713-563-2169
Principal Investigator: David S Hong
Spain
Hospital Universitari Vall d'Hebron
Recruiting
Barcelona, Spain, 08035
Contact 34932746085
Principal Investigator: Elena Garralda Cabanas
Institut Catala d'Oncologia
Recruiting
Barcelona, Spain, 08907
Contact 34932607744
Principal Investigator: Ernest Nadal Alforja
Hospital Universitario 12 de Octubre
Recruiting
Madrid, Spain, 28041
Contact 34913908626
Principal Investigator: Santiago Ponce Aix
Hospital Regional Universitario de Málaga
Recruiting
Malaga, Spain, 29010
Contact 34951030543
Principal Investigator: Manuel Cobo Dols Collapse << |
NCT02906397 | ADVANCED HEPATOCELLULAR CARCIN... more >>OMA (HCC) Collapse << | Phase 1 | Active, not recruiting | January 2019 | United States, Pennsylvania
... more >>
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104 Collapse << |